---
title: "CSPC Pharmaceutical Get China Nod for Herpes Zoster Drug Trial"
date: "2025-02-07 19:00:02"
summary: "CSPC Pharmaceutical Group  obtained approval from China's National Medical Products Administration to conduct clinical trials of SYS6017, a Friday Hong Kong bourse filing said. The drug is designed to prevent herpes zoster infections, according to the pharmaceutical company."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

CSPC Pharmaceutical Group obtained approval from China's National Medical Products Administration to conduct clinical trials of SYS6017, a Friday Hong Kong bourse filing said.

The drug is designed to prevent herpes zoster infections, according to the pharmaceutical company.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250207:G2465120:0/)
